ARQT Competitors & Alternatives
Compare Arcutis Biotherapeutics Inc with similar stocks in the same industry
Biotechnology
ARQT
Main Stock$28.18
Tradestie Score
52
Market Cap
$2.37B
P/E Ratio
124.5
Revenue Growth
0.5%
Analyst Upside
+43.3%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$14.80
|
$3.68B | - | 43 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$93.97
|
$3.67B | - | 38 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$13.38
|
$3.59B | 16.5 | 20 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$18.06
|
$3.58B | 8.6 | 48 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$322.03
|
$3.49B | 126.2 | 55 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$9.36
|
$3.40B | 94.5 | 53 | Compare |
|
QURE
uniQure N.V.
|
$25.22
|
$3.39B | - | 52 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$43.72
|
$3.33B | - | 52 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$20.06
|
$3.31B | - | 44 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
More ARQT Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry